e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension
David Launay, Sébastien Sanges, Vincent Sobanski
Source:
Eur Respir J, 57 (6) 2100205; 10.1183/13993003.00205-2021
Journal Issue:
June
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
David Launay, Sébastien Sanges, Vincent Sobanski. Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension. Eur Respir J, 57 (6) 2100205; 10.1183/13993003.00205-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Screening for pulmonary arterial hypertension in systemic sclerosis
Source: Eur Respir Rev 2009; 18: 162-169
Year: 2009
Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 6-8
Year: 2010
Systemic consequences of pulmonary arterial hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019
Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1800678; 10.1183/13993003.00678-2018
Year: 2018
Differences between limited and diffuse systemic sclerosis-related pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
Identifying early pulmonary arterial hypertension in patients with systemic sclerosis
Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018
Year: 2018
Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis
Source: Eur Respir J 2007; 30: Suppl. 51, 344s
Year: 2007
Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension
Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018
Year: 2018
Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening
Source: Eur Respir Rev 2011; 20: 270-276
Year: 2011
Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
The genetics of pulmonary arterial hypertension
Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling
Year: 2005
The challenges in paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2014; 23: 498-504
Year: 2014
Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA
Source: ERJ Open Res, 6 (2) 00309-2019; 10.1183/23120541.00309-2019
Year: 2020
Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?
Source: Eur Respir J 2010; 35: 223-224
Year: 2010
The revolution of pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 361-363
Year: 2016
Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept